Skip to main content
. 2017 Mar 28;18(4):709. doi: 10.3390/ijms18040709

Table 2.

Nanosized delivery systems for anti-inflammatory phytocannabinoids.

Bioactive Principle Nanovector Type of Delivery System Experimental Model Reference
Δ-9-Tetrahydrocannabinol
Inline graphic
Lipid nanoparticles Nanostructured lipid carriers In vitro [110]
Nanoparticles Lipid NP containing lecithin In vitro [111]
PLGA NP In vitro/In vivo [112]
Cannabidiol loaded PCL NP In vitro [113]
Δ9-THC-loaded PLGA NP In vivo (immunocompetent C57BL/6 mice) [114]